These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19601507)

  • 1. Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea.
    Hershkovitz D; Asna N; Shupak A; Kaminski G; Bar R; Tal D
    Aviat Space Environ Med; 2009 Jul; 80(7):643-6. PubMed ID: 19601507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Habituation of seasickness in adult during a long voyage].
    Li JR; Zhu L; Yuan W; Jin GR; Sun JJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):642-5. PubMed ID: 23141394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cinnarizine in the prevention of seasickness.
    Doweck I; Gordon CR; Spitzer O; Melamed Y; Shupak A
    Aviat Space Environ Med; 1994 Jul; 65(7):606-9. PubMed ID: 7945126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
    Gil A; Nachum Z; Tal D; Shupak A
    Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vestibular evoked myogenic potentials and habituation to seasickness.
    Tal D; Hershkovitz D; Kaminski-Graif G; Wiener G; Samuel O; Shupak A
    Clin Neurophysiol; 2013 Dec; 124(12):2445-9. PubMed ID: 23800706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea.
    Gordon CR; Doweck I; Nachum Z; Gonen A; Spitzer O; Shupak A
    J Vestib Res; 2003; 13(2-3):103-11. PubMed ID: 14757913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sea Voyage Training and Motion Sickness Effects on Working Ability and Life Quality After Landing.
    Qi RR; Xiao SF; Su Y; Mao YQ; Pan LL; Li CH; Lu YL; Wang JQ; Cai YL
    Aerosp Med Hum Perform; 2021 Feb; 92(2):92-98. PubMed ID: 33468289
    [No Abstract]   [Full Text] [Related]  

  • 9. Seasickness as a self-fulfilling prophecy: raising self-efficacy to boost performance at sea.
    Eden D; Zuk Y
    J Appl Psychol; 1995 Oct; 80(5):628-35. PubMed ID: 7592232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of double-dose transdermal scopolamine.
    Bar R; Gil A; Tal D
    Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vestibular evoked myogenic potentials and motion sickness medications.
    Tal D; Shemy S; Kaminski-Graif G; Wiener G; Hershkovitz D
    Clin Neurophysiol; 2016 Jun; 127(6):2350-4. PubMed ID: 27178852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron in multiple sclerosis.
    Macleod AD
    J Pain Symptom Manage; 2000 Nov; 20(5):388-91. PubMed ID: 11068160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginger root against seasickness. A controlled trial on the open sea.
    Grøntved A; Brask T; Kambskard J; Hentzer E
    Acta Otolaryngol; 1988; 105(1-2):45-9. PubMed ID: 3277342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
    Pingree BJ; Pethybridge RJ
    Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-emetic drug effects on pilot performance: granisetron vs. ondansetron.
    Benline TA; French J; Poole E
    Aviat Space Environ Med; 1997 Nov; 68(11):998-1005. PubMed ID: 9383499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural dynamics and habituation to seasickness.
    Tal D; Bar R; Nachum Z; Gil A; Shupak A
    Neurosci Lett; 2010 Jul; 479(2):134-7. PubMed ID: 20493235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
    Korttila K; Clergue F; Leeser J; Feiss P; Olthoff D; Payeur-Michel C; Wessel P; Nave S; Hahne W; Brown R
    Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
    Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
    Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.